STOCK TITAN
  1. Home
  2. Sec-filings
  3. STTK
  4. [SCHEDULE 13G/A] Shattuck Labs, Inc. SEC Filing

[SCHEDULE 13G/A] Shattuck Labs, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock STTK logo
Shattuck Labs, Inc.

NASDAQ:STTK

STTK Rankings

#7459 Ranked by Market Cap
N/A Ranked by Dividends

STTK Latest News

Jul 2, 2025
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
May 1, 2025
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
Apr 2, 2025
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
Mar 27, 2025
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Feb 20, 2025
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

STTK Latest SEC Filings

Jul 16, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity

STTK Stock Data

38.77M
40.95M
14.3%
65.38%
3.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN